iBio, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2014 Annual Meeting of Stockholders held on December 10, 2014. The registrant is iBio, Inc., a Delaware corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders approved three proposals at the annual meeting:
- Proposal 1 (Election of Directors): Mr. John D. McKey, Jr. and Mr. Seymour Flug were elected as Class III directors for a three-year term expiring in 2017.
- Proposal 2 (Auditor Ratification): Stockholders ratified the selection of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2015.
- Proposal 3 (Say on Pay): Stockholders approved, on an advisory basis, the compensation of named executive officers.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the definitive proxy statement filed on November 12, 2014, for detailed descriptions of the proposals.
- Confirm the specific voting thresholds required for director elections and advisory votes under Delaware law.
- Review the upcoming 10-K or 10-Q for the fiscal year ending June 30, 2015, to obtain financial performance data not included in this 8-K.